Efficacy of Blood Purification Techniques on COVID-19 Pneumonia

Phase 3

• Conditions: covid-19 patients.; COVID-19 Disease; U07.1

• Registration Number: IRCT20150107020592N29
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

covid-19 patients
PaO2/FiO2 ratio (partial pressure of arterial oxygen/fraction of inspired oxygen) under 150
Interloquin 6 above 100 pg/ml

Exclusion Criteria

Patients under 18 years of age

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxygenation. Timepoint: Daily after the procedure until discharge or death. Method of measurement: pulse Oximetry.;Mortality. Timepoint: discharge time. Method of measurement: Death.;Interleukin 6. Timepoint: Measurement of interleukin at intervals of one, six and seven days. Method of measurement: laboratory kit.